|
|
Article: Genes R us.(includes related article on biotechnology breakthroughs)(privately-owned, genomics biotechnology firm Human Genome Sciences)(Cover Story)
- Article from:
- Chief Executive (U.S.)
- Article date:
- June 1, 1999
- Author:
CopyrightCOPYRIGHT 1999 Chief Executive Magazine. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
If the 20th century was the age of subatomic physics, the 21st century will belong to molecular bioscience. CEO William Haseltine reckons his company, Human Genome Sciences, is at the vanguard of new genetic technologies which will usher in bioscience's next wave - regenerative medicine. It's a wave he hopes will turn his seven year old startup into the next - hold onto your petri dish - Merck or Pfizer.
The cloning of a sheep named "Dolly" in 1997 was the headline event that underscored how the frontiers of science are being pushed further and faster than the public's ability to come to terms with their social implications. Since the discovery of DNA, the ...